Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Net Margin (2024 - 2025)

Rallybio (RLYB) has disclosed Net Margin for 2 consecutive years, with 2636.04% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 2529554.0% to 2636.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 944.52% through Dec 2025, up 778755.0% year-over-year, with the annual reading at 944.52% for FY2025, 778755.0% up from the prior year.
  • Net Margin hit 2636.04% in Q4 2025 for Rallybio, down from 7554.72% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 7554.72% in Q3 2025 to a low of 27931.58% in Q4 2024.